secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001654954-23-005633
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences closes $4.5M public stock & warrant offering, over-allotment fully exercised
--------------------------------------------------------------------------------

- Offering of 4,312,500 shares + warrants for 2,156,250 shares at $2.41 per set (2 shares + 1 warrant).
- Net proceeds of $4.5 million; warrants exercisable at $1.40 per share for 5 years.
- Proceeds to fund working capital, product development, regulatory submissions, and commercialization.
- Newbridge Securities acted as sole underwriter; warrants will not be listed on any exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495423005633/0001654954-23-005633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495423005633/ndra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-005633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer